DHODH-IN-4
CAS No. 1148125-93-2
DHODH-IN-4( —— )
Catalog No. M26158 CAS No. 1148125-93-2
DHODH-IN-4 is a human and Plasmodium falciparum dihydroorotate dehydrogenase (DHODH) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 261 | In Stock |
|
| 2MG | 166 | In Stock |
|
| 5MG | 256 | In Stock |
|
| 10MG | 375 | In Stock |
|
| 25MG | 562 | In Stock |
|
| 50MG | 776 | In Stock |
|
| 100MG | 1042 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2102 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDHODH-IN-4
-
NoteResearch use only, not for human use.
-
Brief DescriptionDHODH-IN-4 is a human and Plasmodium falciparum dihydroorotate dehydrogenase (DHODH) inhibitor.
-
DescriptionDHODH-IN-4 is a human and Plasmodium falciparum dihydroorotate dehydrogenase (DHODH) inhibitor. The IC50 values of PfDHODH and HsDHODH are 4 μM and 0.18 μM, respectively. DHODH-IN-4 has antimalarial activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorH1 receptor| M1 mAChR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1148125-93-2
-
Formula Weight347.2
-
Molecular FormulaC17H12Cl2N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC\C(O)=C(/C#N)C(=O)Nc1ccc(cc1Cl)-c1ccccc1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.S W Lee, et al.Selectivity of oxomemazine for the M1 muscarinic receptors.Arch Pharm Res. 1994 Dec;17(6):443-51.
molnova catalog
related products
-
Alendronate sodium h...
Alendronate sodium hydrate (Alendronate;MK 217;G-704650 Adronat) is a bisphosphonate that acts as a specific inhibitor of osteoclastmediated bone resorption.
-
Glucoliquiritin
Glucoliquiritin is a natural product for research related to life sciences.
-
PACAP (1-38), human,...
PACAP (1-38), a novel neuropeptide isolated from the bovine hypothalamus is more active than vasoactive intestinal peptide (VIP) in stimulating adenylate cyclase (EC50=7 nM). PACAP 1-38 (10-9 M) increased substance P (SP), gastrin releasing peptide (GRP), and VIP release. PACAP 1-38 (10-8 M) inhibited gastrin secretion and stimulated somatostatin secretion and motility dose-dependently.
Cart
sales@molnova.com